P/E ratio for Phio Pharmaceuticals (PHIO)
P/E ratio as of April 2025 (TTM): -0.1221
According to Phio Pharmaceuticals's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.122095. At the end of 2022 the company had a P/E ratio of -3.98.
P/E ratio history for Phio Pharmaceuticals from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -3.98 | -53.33% |
| 2021 | -8.53 | -12.65% |
| 2020 | -9.76 | 125.52% |
| 2019 | -4.33 | 162.34% |
| 2018 | -1.65 | -81.34% |
| 2017 | -8.84 | 121.95% |
| 2016 | -3.98 | -75.38% |
| 2015 | -16.2 | -12.16% |
| 2014 | -18.4 | 88.97% |
| 2013 | -9.75 | 138.95% |
| 2012 | -4.08 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | -0.9953 | 715.18% | 🇺🇸 USA |
 | -6.13 | 4,920.38% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.